Quite just lately, preliminary benefits from a third trial comparing ibrutinib vs . observation were presented.105 People getting ibrutinib experienced a longer party-free of charge survival, but no In general survival benefit, although the results were nonetheless immature. Additionally, Though intense adverse occasions prices ended up similar con